Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis

Abstract Background Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system. Evidences linking apolipoprotein E (APOE) to myelin repair, neuronal plasticity, and cerebral inflammatory processes suggest that it may be relevant in MS. The main goal of thi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the neurological sciences 2012-09, Vol.320 (1), p.22-25
Hauptverfasser: Rafiei, Mahdi, Zarif Yeganeh, Marjan, Sheikholeslami, Sara, Gozalpour, Elnaz, Ghaffarpour, Majid, Hedayati, Mehdi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system. Evidences linking apolipoprotein E (APOE) to myelin repair, neuronal plasticity, and cerebral inflammatory processes suggest that it may be relevant in MS. The main goal of this study was to determine whether the APOE genotypes and alleles are associated with MS patients. Materials and methods In total, 147 MS cases and 168 control subjects from Iranian population were genotyped for APOE gene using PCR-RFLP method. Results The frequency of APOE-ε2ε3 genotype was significantly higher in controls than cases (14.3% vs. 6.1%, P = 0.009, OR = 0.39) whereas APOE-ε3ε4 genotype frequency was significantly higher in cases compared with controls (8.2% vs. 3.6%, P = 0.03, OR = 2.4). APOE-ε2 allele frequency in cases was significantly lower than that of controls (4.4% vs. 8.0%, P = 0.03, OR = 0.52). Also male controls were significantly more likely to have APOE-ε2 allele (7.8% vs. 1%, P = 0.01, OR = 0.11). APOE‐ε4 allele frequency in cases was significantly higher than control group (4.8% versus 2.1%, P = 0.03, OR = 2.35). Conclusion It seems that individuals carrying APOE‐ε4 allele and/or APOE-ε3ε4 genotype develop MS two times more than non-carriers. Also APOE-ε2ε3 genotype or APOE-ε2 allele may have a protective role against MS development in Iranian population. Further investigation would be warranted to understand the role of APOE alleles and genotypes and risk of MS.
ISSN:0022-510X
1878-5883
DOI:10.1016/j.jns.2012.05.050